Results 1 to 10 of about 2,079,641 (409)

Prognostic value of C-reactive protein levels in patients with bone neoplasms: A meta-analysis. [PDF]

open access: goldPLoS ONE, 2018
The aim of this study was to conduct a meta-analysis of retrospective studies that investigated the association of preoperative C-reactive protein (CRP) levels with the overall survival (OS) of patients with bone neoplasms.A detailed literature search ...
Wenyi Li   +4 more
doaj   +5 more sources

miRNA-128 modulates bone neoplasms cells proliferation and migration through the WNT/β-catenin and EMT signal pathways [PDF]

open access: yesJournal of Orthopaedic Surgery and Research, 2021
Background Bone neoplasms present poor prognosis due to recurrence and metastasis. Although the role microRNAs (miRNAs) in inhibiting growth and metastasis of bone neoplasms has been investigated, the underlying potential molecular mechanisms mediated by
Yang Li   +4 more
doaj   +3 more sources

Bone marrow niche dysregulation in myeloproliferative neoplasms

open access: goldHaematologica, 2020
The bone marrow niche is a complex and dynamic structure composed of a multitude of cell types which functionally create an interactive network facilitating hematopoietic stem cell development and maintenance.
N. Curto-Garcia   +2 more
semanticscholar   +7 more sources

β-elemene enhances anticancer bone neoplasms efficacy of paclitaxel through regulation of GPR124 in bone neoplasms cells. [PDF]

open access: yesOncol Lett, 2018
The purpose of the present study was to investigate the anticancer effects of β-elemene and paclitaxel for bone neoplasms. MTT assay, reverse transcription-quantitative polymerase chain reaction, western blotting, flow cytometry and immunostaining were ...
Wang Z, Li Y, Zhou F, Piao Z, Hao J.
europepmc   +2 more sources

Long Non-Coding RNA HULC Promotes Progression of Bone Neoplasms. [PDF]

open access: yesMed Sci Monit, 2018
Background Bone neoplasms are common in humans and have high lethality. Recently, great progress has been made in understanding the pathophysiological mechanisms, but little is known about the molecular and genetic networks involved. Material/Methods qRT-
Zhang T, Wan CY, Mei XL, Jia P, Wang MJ.
europepmc   +2 more sources

Bone marrow niches in myeloid neoplasms [PDF]

open access: hybridPathology International, 2019
Pathological phenotypes of myeloid neoplasms are closely related to genetic/chromosomal abnormalities of neoplastic cells whereas the bone marrow microenvironment, including stromal elements and hematopoietic stem cell niche cells, have a great influence on the differentiation/proliferation of both hematopoietic and neoplastic cells.
Masanobu Kitagawa   +3 more
openalex   +4 more sources

Differential expression of CD200 in B-cell neoplasms by flow cytometry can assist in diagnosis, subclassification, and bone marrow staging. [PDF]

open access: bronzeAmerican Journal of Clinical Pathology, 2014
OBJECTIVES To analyze CD200 expression by flow cytometry in a large series of B-cell neoplasms in a variety of tissue types in comparison with benign B-lineage cells. METHODS We measured CD200 expression levels in 505 peripheral blood (PB), bone marrow
Pramoda Challagundla   +4 more
semanticscholar   +2 more sources

Primary bone neoplasms in dogs: 90 cases [PDF]

open access: goldPesquisa Veterinária Brasileira, 2012
A retrospective study of necropsy and biopsy cases of 90 primary bone tumors (89 malignant and one benign) in dogs received over a period of 22 years at the Laboratório de Patologia Veterinária, Universidade Federal de Santa Maria, was performed ...
Maria E. Trost   +7 more
doaj   +2 more sources

Genetic effect of basal metabolic rate on the benign neoplasm of bone and articular cartilage: a Mendelian randomization study [PDF]

open access: yesFrontiers in Oncology
BackgroundPrevious studies have found an association between basal metabolic rate (BMR) and various malignant neoplasms, including bone tumors. BMR is also associated with bone mineral density, but the causality between BMR and benign neoplasms of bone ...
Guijin Huang   +11 more
doaj   +2 more sources

Myeloproliferative neoplasms with concurrent BCR–ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group [PDF]

open access: bronzeModern Pathology, 2018
Craig R. Soderquist   +12 more
semanticscholar   +2 more sources

Home - About - Disclaimer - Privacy